Sam Carl

Title: Innovations by Sam Carl in Drug Delivery Technology

Introduction

Sam Carl is an innovative inventor based in Waltham, MA (US). He has made significant contributions to the field of drug delivery technology, particularly for diabetic patients. His work focuses on enhancing the efficiency and safety of insulin delivery systems.

Latest Patents

Sam Carl holds a patent for an invention titled "Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation." This patent describes a drug delivery device that can receive glucose level values from a user, such as a diabetic patient. The device determines when the user has consumed a meal and calculates an appropriate bolus dose for insulin delivery. The device can also allow the user to manually announce a meal, triggering the calculation and delivery of the drug bolus. Additionally, the device may relax safety constraints for a period following the bolus delivery to allow for additional basal drug delivery if necessary.

Career Highlights

Sam Carl is currently employed at Insulet Corporation, a company known for its innovative medical devices. His work at Insulet has positioned him as a key player in the development of advanced drug delivery systems. His patent reflects his commitment to improving the lives of diabetic patients through technology.

Collaborations

Sam collaborates with talented individuals such as Rangarajan Narayanaswami and Yibin Zheng. Their combined expertise contributes to the advancement of drug delivery solutions.

Conclusion

Sam Carl's contributions to drug delivery technology demonstrate his dedication to innovation in healthcare. His patent showcases the potential for improved management of diabetes through automated systems. His work continues to pave the way for advancements in medical technology.